Clinical trial
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
NCT03274856 is registered in ClinicalTrials.gov with GLWL Research Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
- Lead sponsor
- GLWL Research Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 20, 2018
- Completion date
- June 12, 2019
- Enrollment
- 19 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.